FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Wells

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Mammalian Embryo

Physiology

Disorders

Phenomena

Oxidation-Reduction

Co-author Network

Publications

TOP 3
Stephanie L Ondovcik; Laura Tamblyn; John Peter McPherson; Peter G Wells
Sensitivity to methylmercury toxicity is enhanced in oxoguanine glycosylase 1 knockout murine embryonic fibroblasts and is dependent on cellular proliferation capacity.
Lutfiya Miller; Aaron M Shapiro; Jun Cheng; Peter G Wells
The free radical spin trapping agent phenylbutylnitrone reduces fetal brain DNA oxidation and postnatal cognitive deficits caused by in utero exposure to a non-structurally teratogenic dose of ethanol: A role for oxidative stress.
Michelle T Siu; Michael J Wiley; Peter G Wells
Methanol teratogenicity in mutant mice with deficient catalase activity and transgenic mice expressing human catalase.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Wells (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stephanie L Ondovcik; Laura Tamblyn; John Peter McPherson; Peter G Wells
Sensitivity to methylmercury toxicity is enhanced in oxoguanine glycosylase 1 knockout murine embryonic fibroblasts and is dependent on cellular proliferation capacity.
Toxicology and applied pharmacology 2013;270(1):23-30.
2013: Lutfiya Miller; Aaron M Shapiro; Jun Cheng; Peter G Wells
The free radical spin trapping agent phenylbutylnitrone reduces fetal brain DNA oxidation and postnatal cognitive deficits caused by in utero exposure to a non-structurally teratogenic dose of ethanol: A role for oxidative stress.
Free radical biology & medicine 2013;60():223-32.
2013: Michelle T Siu; Michael J Wiley; Peter G Wells
Methanol teratogenicity in mutant mice with deficient catalase activity and transgenic mice expressing human catalase.
Reproductive toxicology (Elmsford, N.Y.) 2013;36():33-9.
2012: Julia P Abramov; Aaron M Shapiro; Audrey Tran; Peter G Wells
Protective role of endogenous catalase in baseline and phenytoin-enhanced neurodevelopmental and behavioral deficits initiated in utero and in aged mice.
Reproductive toxicology (Elmsford, N.Y.) 2012;33(3):361-73.
2011: Crystal J J Lee; Norio Shibata; Michael J Wiley; Peter G Wells
Fluorothalidomide: a characterization of maternal and developmental toxicity in rabbits and mice.
Toxicological sciences : an official journal of the Society of Toxicology 2011;122(1):157-69.
2011: Crystal J J Lee; Luisa L Gonçalves; Peter G Wells
Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011;25(7):2468-83.
2011: Julia P Abramov; Peter G Wells
Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011;25(7):2188-200.
2011: Lutfiya Miller; Peter G Wells
Altered methanol embryopathies in embryo culture with mutant catalase-deficient mice and transgenic mice expressing human catalase.
Toxicology and applied pharmacology 2011;252(1):55-61.
2011: Annmarie Ramkissoon; Peter G Wells
Human prostaglandin H synthase (hPHS)-1 and hPHS-2 in amphetamine analog bioactivation, DNA oxidation, and cytotoxicity.
Toxicological sciences : an official journal of the Society of Toxicology 2011;120(1):154-62.
2011: Gordon P McCallum; Michelle Siu; Stephanie L Ondovcik; J Nicole Sweeting; Peter G Wells
Methanol exposure does not lead to accumulation of oxidative DNA damage in bone marrow and spleen of mice, rabbits or primates.
Molecular carcinogenesis 2011;50(3):163-72.
2011: Gordon P McCallum; Andrea W Wong; Peter G Wells
Cockayne syndrome B protects against methamphetamine-enhanced oxidative DNA damage in murine fetal brain and postnatal neurodevelopmental deficits.
Antioxidants & redox signaling 2011;14(5):747-56.
2011: Winnie Jeng; Annmarie Ramkissoon; Peter G Wells
Reduced DNA oxidation in aged prostaglandin H synthase-1 knockout mice.
Free radical biology & medicine 2011;50(4):550-6.
2011: Annmarie Ramkissoon; Peter G Wells
Human prostaglandin H synthase (hPHS)-1- and hPHS-2-dependent bioactivation, oxidative macromolecular damage, and cytotoxicity of dopamine, its precursor, and its metabolites.
Free radical biology & medicine 2011;50(2):295-304.
2011: Gordon P McCallum; Michelle Siu; J Nicole Sweeting; Peter G Wells
Methanol exposure does not produce oxidatively damaged DNA in lung, liver or kidney of adult mice, rabbits or primates.
Toxicology and applied pharmacology 2011;250(2):147-53.
2011: J Nicole Sweeting; Michelle Siu; Michael J Wiley; Peter G Wells
Species- and strain-dependent teratogenicity of methanol in rabbits and mice.
Reproductive toxicology (Elmsford, N.Y.) 2011;31(1):50-8.
2010: J Nicole Sweeting; Michelle Siu; Gordon P McCallum; Lutfiya Miller; Peter G Wells
Species differences in methanol and formic acid pharmacokinetics in mice, rabbits and primates.
Toxicology and applied pharmacology 2010;247(1):28-35.
2010: Peter G Wells; Gordon P McCallum; Kyla C H Lam; Dr. Jeffrey Henderson; Stephanie L Ondovcik
Oxidative DNA damage and repair in teratogenesis and neurodevelopmental deficits.
Birth defects research. Part C, Embryo today : reviews 2010;90(2):103-9.
2010: Peter G Wells; Crystal J J Lee; Gordon P McCallum; Julia Perstin; Patricia A Harper
Receptor- and reactive intermediate-mediated mechanisms of teratogenesis.
Handbook of experimental pharmacology 2010;(196):131-62.
2009: Tuula M Kalliomäki; Gordon McCallum; Peter G Wells; Richard P Hill
Progression and metastasis in a transgenic mouse breast cancer model: effects of exposure to in vivo hypoxia.
Cancer letters 2009;282(1):98-108.
2009: Thomas J Preston; Dr. Jeffrey Henderson; Gordon P McCallum; Peter G Wells
Base excision repair of reactive oxygen species-initiated 7,8-dihydro-8-oxo-2'-deoxyguanosine inhibits the cytotoxicity of platinum anticancer drugs.
Molecular cancer therapeutics 2009;8(7):2015-26.
2009: Luísa L Gonçalves; Annmarie Ramkissoon; Peter G Wells
Prostaglandin H synthase-1-catalyzed bioactivation of neurotransmitters, their precursors, and metabolites: oxidative DNA damage and electron spin resonance spectroscopy studies.
Chemical research in toxicology 2009;22(5):842-52.
2009: Connie S Chen; Jeremy A Squire; Peter G Wells
Reduced tumorigenesis in p53 knockout mice exposed in utero to low-dose vitamin E.
Cancer 2009;115(7):1563-75.
2009: Peter G Wells; Gordon P McCallum; Connie S Chen; Dr. Jeffrey Henderson; Crystal J J Lee; Julia Perstin; Thomas J Preston; Michael J Wiley; Andrea W Wong
Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer.
Toxicological sciences : an official journal of the Society of Toxicology 2009;108(1):4-18.
2008: Andrea W Wong; Gordon P McCallum; Winnie Jeng; Peter G Wells
Oxoguanine glycosylase 1 protects against methamphetamine-enhanced fetal brain oxidative DNA damage and neurodevelopmental deficits.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(36):9047-54.
2006: Yadvinder Bhuller; Peter G Wells
A developmental role for ataxia-telangiectasia mutated in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture.
Toxicological sciences : an official journal of the Society of Toxicology 2006;93(1):156-63.
2006: Yadvinder Bhuller; Winnie Jeng; Peter G Wells
Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice.
Toxicological sciences : an official journal of the Society of Toxicology 2006;93(1):146-55.
2006: Connie S Chen; Peter G Wells
Enhanced tumorigenesis in p53 knockout mice exposed in utero to high-dose vitamin E.
Carcinogenesis 2006;27(7):1358-68.
2006: Winnie Jeng; Annmarie Ramkissoon; Toufan Parman; Peter G Wells
Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(6):638-50.
2005: Peter G Wells; Yadvinder Bhuller; Connie S Chen; Winnie Jeng; Sonja Kasapinovic; Julia C Kennedy; Perry M Kim; Rebecca R Laposa; Gordon P McCallum; Christopher J Nicol; Toufan Parman; Michael J Wiley; Andrea W Wong
Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species.
Toxicology and applied pharmacology 2005;207(2 Suppl):354-66.
2005: Winnie Jeng; Andrea W Wong; Ryan Ting-A-Kee; Peter G Wells
Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits.
Free radical biology & medicine 2005;39(3):317-26.
2004: Connie Shihsin Chen; Peter G Wells
In utero origins of cancer: maternal dietary vitamin E, fetal oxidative DNA damage, and postnatal carcinogenesis in p53 knockout mice.
Annals of the New York Academy of Sciences 2004;1031():395-8.
2004: Sonja Kasapinovic; Gordon P McCallum; Michael J Wiley; Peter G Wells
The peroxynitrite pathway in development: phenytoin and benzo[a]pyrene embryopathies in inducible nitric oxide synthase knockout mice.
Free radical biology & medicine 2004;37(11):1703-11.
2004: Julia C Kennedy; Sylvie Memet; Peter G Wells
Antisense evidence for nuclear factor-kappaB-dependent embryopathies initiated by phenytoin-enhanced oxidative stress.
Molecular pharmacology 2004;66(3):404-12.
2004: Rebecca R Laposa; Dr. Jeffrey Henderson; Elaine Xu; Peter G Wells
Atm-null mice exhibit enhanced radiation-induced birth defects and a hybrid form of embryonic programmed cell death indicating a teratological suppressor function for ATM.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(7):896-8.
2004: Peter G Wells; Peter I Mackenzie; Jayanta Roy-Chowdhury; Chantal Guillemette; Philip A Gregory; Yuji Ishii; Antony J Hansen; Fay K Kessler; Perry M Kim; Namita Roy-Chowdhury; Joseph K Ritter
Glucuronidation and the UDP-glucuronosyltransferases in health and disease.
Drug metabolism and disposition: the biological fate of chemicals 2004;32(3):281-90.
2004: Zhuohan Hu; Peter G Wells
Human interindividual variation in lymphocyte UDP-glucuronosyltransferases as a determinant of in vitro benzo[a]pyrene covalent binding and cytotoxicity.
Toxicological sciences : an official journal of the Society of Toxicology 2004;78(1):32-40.
2003: Rebecca R Laposa; Dr. Jeffrey Henderson; Peter G Wells
Tetracycline-dependent regulation of formamidopyrimidine DNA glycosylase in transgenic mice conditionally reduces oxidative DNA damage in vivo.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(10):1343-5.
2002: Louise M Winn; Peter G Wells
Evidence for Ras-dependent signal transduction in phenytoin teratogenicity.
Toxicology and applied pharmacology 2002;184(3):144-52.
2002: Toufan Parman; Peter G Wells
Embryonic prostaglandin H synthase-2 (PHS-2) expression and benzo[a]pyrene teratogenicity in PHS-2 knockout mice.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(9):1001-9.
2000: Christopher J Nicol; Julian Zielenski; L C Tsui; Peter G Wells
An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(1):111-27.
1999: Toufan Parman; Michael J Wiley; Peter G Wells
Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
Nature medicine 1999;5(5):582-5.
1999: Louise M Winn; Peter G Wells
Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity.
Free radical biology & medicine 1999;26(3-4):266-74.
1998: Louise M Winn; Perry M Kim; Peter G Wells
Investigation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone for in vivo and iIn vitro murine embryopathy and embryonic ras mutations.
The Journal of pharmacology and experimental therapeutics 1998;287(3):1128-35.
1998: Toufan Parman; G Chen; Peter G Wells
Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis.
The Journal of biological chemistry 1998;273(39):25079-88.
1997: Peter G Wells; Perry M Kim; Rebecca R Laposa; Christopher J Nicol; Toufan Parman; Louise M Winn
Oxidative damage in chemical teratogenesis.
Mutation research 1997;396(1-2):65-78.
1997: Sharon L Walmsley; Louise M Winn; M L Harrison; Jack P Uetrecht; Peter G Wells
Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: toxicological and pathological implications.
AIDS (London, England) 1997;11(14):1689-97.
1997: Perry M Kim; U DeBoni; Peter G Wells
Peroxidase-dependent bioactivation and oxidation of DNA and protein in benzo[a]pyrene-initiated micronucleus formation.
Free radical biology & medicine 1997;23(4):579-96.
1997: Louise M Winn; Peter G Wells
Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis.
Free radical biology & medicine 1997;22(4):607-21.
1997: Perry M Kim; Louise M Winn; Toufan Parman; Peter G Wells
UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin.
The Journal of pharmacology and experimental therapeutics 1997;280(1):200-9.
1996: R R Arlen; Peter G Wells
Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate.
The Journal of pharmacology and experimental therapeutics 1996;277(3):1649-58.
1996: T R Ozolins; D L Siksay; Peter G Wells
Modulation of embryonic glutathione peroxidase activity and phenytoin teratogenicity by dietary deprivation of selenium in CD-1 mice.
The Journal of pharmacology and experimental therapeutics 1996;277(2):945-53.
1996: Perry M Kim; Peter G Wells
Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene.
Cancer research 1996;56(7):1526-32.
1996: Peter G Wells; Louise M Winn
Biochemical toxicology of chemical teratogenesis.
Critical reviews in biochemistry and molecular biology 1996;31(1):1-40.
1996: Perry M Kim; Peter G Wells
Phenytoin-initiated hydroxyl radical formation: characterization by enhanced salicylate hydroxylation.
Molecular pharmacology 1996;49(1):172-81.
1995: T R Ozolins; M J Wiley; Peter G Wells
Phenytoin covalent binding and embryopathy in mouse embryos co-cultured with maternal hepatocytes from mouse, rat, and rabbit.
Biochemical pharmacology 1995;50(11):1831-40.
1995: L Liu; Peter G Wells
DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2'-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues.
Free radical biology & medicine 1995;19(5):639-48.
1995: T R Ozolins; L A Oglesby; M J Wiley; Peter G Wells
In vitro murine embryotoxicity of cyclophosphamide in embryos co-cultured with maternal hepatocytes: development and application of a murine embryo-hepatocyte co-culture model.
Toxicology 1995;102(3):259-74.
1995: L Liu; Peter G Wells
Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
Toxicology and applied pharmacology 1995;134(1):71-80.
1995: Peter G Wells; B Wilson; Louise M Winn; B M Lubek
In vivo murine studies on the biochemical mechanism of acetaminophen cataractogenicity.
Canadian journal of physiology and pharmacology 1995;73(8):1123-9.
1995: Louise M Winn; Peter G Wells
Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
Molecular pharmacology 1995;48(1):112-20.
1995: C J Nicol; M L Harrison; R R Laposa; I L Gimelshtein; Peter G Wells
A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice.
Nature genetics 1995;10(2):181-7.
1995: W K Yu; Peter G Wells
Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice.
Toxicology and applied pharmacology 1995;131(1):1-12.
1995: D S Vienneau; U DeBoni; Peter G Wells
Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts.
Cancer research 1995;55(5):1045-51.
1994: Z Hu; Peter G Wells
Modulation of benzo[a]pyrene bioactivation by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP-glucuronosyltransferase.
Toxicology and applied pharmacology 1994;127(2):306-13.
1994: L Liu; Peter G Wells
In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
Toxicology and applied pharmacology 1994;125(2):247-55.
1994: A F Miranda; M J Wiley; Peter G Wells
Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
Toxicology and applied pharmacology 1994;124(2):230-41.
1992: S M de Morais; S Y Chow; Peter G Wells
Biotransformation and toxicity of acetaminophen in congenic RHA rats with or without a hereditary deficiency in bilirubin UDP-glucuronosyltransferase.
Toxicology and applied pharmacology 1992;117(1):81-7.
1992: Z Hu; Peter G Wells
In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase.
The Journal of pharmacology and experimental therapeutics 1992;263(1):334-42.
1992: S M de Morais; J P Uetrecht; Peter G Wells
Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome.
Gastroenterology 1992;102(2):577-86.
1990: G M Kalabis; Peter G Wells
Biphasic modulation of acetaminophen bioactivation and hepatotoxicity by pretreatment with the interferon inducer polyinosinic-polycytidylic acid.
The Journal of pharmacology and experimental therapeutics 1990;255(3):1408-19.
1989: M J Shanks; M J Wiley; S Kubow; Peter G Wells
Phenytoin embryotoxicity: role of enzymatic bioactivation in a murine embryo culture model.
Teratology 1989;40(4):311-20.
1989: M Wong; L M Helston; Peter G Wells
Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate.
Teratology 1989;40(2):127-41.
1989: S M de Morais; Peter G Wells
Enhanced acetaminophen toxicity in rats with bilirubin glucuronyl transferase deficiency.
Hepatology (Baltimore, Md.) 1989;10(2):163-7.
1989: Peter G Wells; B Wilson; B M Lubek
In vivo murine studies on the biochemical mechanism of naphthalene cataractogenesis.
Toxicology and applied pharmacology 1989;99(3):466-73.
1989: M Wong; Peter G Wells
Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
The Journal of pharmacology and experimental therapeutics 1989;250(1):336-42.
1989: S Kubow; Peter G Wells
In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
Molecular pharmacology 1989;35(4):504-11.
1989: Peter G Wells; M K Nagai; G S Greco
Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds.
Toxicology and applied pharmacology 1989;97(3):406-14.
1989: Peter G Wells; H P Vo
Effects of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate on phenytoin-induced embryopathy in mice.
Toxicology and applied pharmacology 1989;97(3):398-405.
1989: Peter G Wells; J T Zubovits; S T Wong; L M Molinari; S Ali
Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
Toxicology and applied pharmacology 1989;97(2):192-202.
1989: B M Lubek; S Kubow; P K Basu; Peter G Wells
Cataractogenicity and bioactivation of naphthalene derivatives in lens culture and in vivo.
Lens and eye toxicity research 1989;6(1-2):203-9.
1988: S M de Morais; Peter G Wells
Deficiency in bilirubin UDP-glucuronyl transferase as a genetic determinant of acetaminophen toxicity.
The Journal of pharmacology and experimental therapeutics 1988;247(1):323-31.
1988: B M Lubek; P K Basu; Peter G Wells
Metabolic evidence for the involvement of enzymatic bioactivation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL/6) and resistant (DBA/2) murine strains.
Toxicology and applied pharmacology 1988;94(3):487-95.
1988: B M Lubek; M Avaria; P K Basu; Peter G Wells
Pharmacological studies on the in vivo cataractogenicity of acetaminophen in mice and rabbits.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1988;10(4):596-606.
1988: M Wong; Peter G Wells
Effects of N-acetylcysteine on fetal development and on phenytoin teratogenicity in mice.
Teratogenesis, carcinogenesis, and mutagenesis 1988;8(2):65-79.